| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |